% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Herdick:155279,
author = {Herdick, Meret-Luise and Dyrba, Martin and Fritz,
Hans-Christian J and Altenstein, Slawek and Ballarini,
Tommaso and Brosseron, Frederic and Bürger, Katharina and
Can Cetindag, Arda and Dechent, Peter and Dobisch, Laura and
Düzel, Emrah and Ertl-Wagner, Birgit and Fliessbach, Klaus
and Dawn Freiesleben, Silka and Frommann, Ingo and Glanz,
Wenzel and Dylan Haynes, John and Heneka, Michael T and
Janowitz, Daniel and Kilimann, Ingo and Laske, Christoph and
Metzger, Coraline D and Munk, Mathias H. and Peters, Oliver
and Priller, Josef and Roy, Nina and Scheffler, Klaus and
Schneider, Anja and Spottke, Annika and Spruth, Eike Jakob
and Tscheuschler, Maike and Vukovich, Ruth and Wiltfang,
Jens and Jessen, Frank and Teipel, Stefan and Grothe, Michel
J},
title = {{M}ultimodal {MRI} analysis of basal forebrain structure
and function across the {A}lzheimer's disease spectrum.},
journal = {NeuroImage: Clinical},
volume = {28},
issn = {2213-1582},
address = {[Amsterdam u.a.]},
publisher = {Elsevier},
reportid = {DZNE-2021-00559},
pages = {102495},
year = {2020},
abstract = {Dysfunction of the cholinergic basal forebrain (cBF) is
associated with cognitive decline in Alzheimer's disease
(AD). Multimodal MRI allows for the investigation of cBF
changes in-vivo. In this study we assessed alterations in
cBF functional connectivity (FC), mean diffusivity (MD), and
volume across the spectrum of AD. We further assessed
effects of amyloid pathology on these changes.Participants
included healthy controls, and subjects with subjective
cognitive decline (SCD), mild cognitive impairment (MCI), or
AD dementia (ADD) from the multicenter DELCODE study.
Resting-state functional MRI (rs-fMRI) and structural MRI
data was available for 477 subjects, and a subset of 243
subjects also had DTI data available. Differences between
diagnostic groups were investigated using seed-based FC,
volumetric, and MD analyses of functionally defined anterior
(a-cBF) and posterior (p-cBF) subdivisions of a
cytoarchitectonic cBF region-of-interest. In complementary
analyses groups were stratified according to amyloid status
based on CSF Aβ42/40 biomarker data, which was available in
a subset of participants.a-cBF and p-cBF subdivisions showed
regional FC profiles that were highly consistent with
previously reported patterns, but there were only minimal
differences between diagnostic groups. Compared to controls,
cBF volumes and MD were significantly different in MCI and
ADD but not in SCD. The Aβ42/40 stratified analyses largely
matched these results.We reproduced subregion-specific FC
profiles of the cBF in a clinical sample spanning the AD
spectrum. At least in this multicentric cohort study, cBF-FC
did not show marked changes along the AD spectrum, and
multimodal MRI did not provide more sensitive measures of
AD-related cBF changes compared to volumetry.},
keywords = {Alzheimer Disease: diagnostic imaging / Basal Forebrain:
diagnostic imaging / Cognitive Dysfunction: diagnostic
imaging / Cohort Studies / Humans / Magnetic Resonance
Imaging / Alzheimer’s Disease (Other) / Cholinergic Basal
Forebrain (Other) / Functional Connectivity (Other) / Mean
Diffusivity (Other) / Resting-state fMRI (Other) /
Subjective Cognitive Decline (Other)},
cin = {AG Schneider / AG Teipel / AG Endres / AG Wagner /
Biomarker / Clinical Research (Munich) / Patient Studies
Bonn / AG Speck / AG Klockgether / Clinical Research
Platform (CRP) / AG Priller / Core ICRU / AG Düzel / AG
Jessen / AG Wiltfang / AG Gasser / Delcode},
ddc = {610},
cid = {I:(DE-2719)1011305 / I:(DE-2719)1510100 /
I:(DE-2719)1811005 / I:(DE-2719)1011201 / I:(DE-2719)1011301
/ I:(DE-2719)1111015 / I:(DE-2719)1011101 /
I:(DE-2719)1340009 / I:(DE-2719)1011001 / I:(DE-2719)1011401
/ I:(DE-2719)5000007 / I:(DE-2719)1240005 /
I:(DE-2719)5000006 / I:(DE-2719)1011102 / I:(DE-2719)1410006
/ I:(DE-2719)1210000 / I:(DE-2719)5000034},
pnm = {344 - Clinical and Health Care Research (POF3-344) / 342 -
Disease Mechanisms and Model Systems (POF3-342)},
pid = {G:(DE-HGF)POF3-344 / G:(DE-HGF)POF3-342},
experiment = {EXP:(DE-2719)DELCODE-20140101},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:33395986},
pmc = {pmc:PMC7689403},
doi = {10.1016/j.nicl.2020.102495},
url = {https://pub.dzne.de/record/155279},
}